[Insulin therapy in patients with type 2 diabetes].
Siegmund
T
T
Klinik für Endokrinologie, Diabetologie und Angiologie, Städt. Klinikum München GmbH, Klinikum Bogenhausen, München. thorsten.siegmund@kh-bogenhausen.de
Schumm-Draeger
P-M
PM
D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin